Solution-phase combinatorial chemistry was applied to the optimization and
development of clinical candidate OC144-093 (22), a novel and nontoxic modu
lator of P-glycoprotein mediated multidrug resistance. (C) 2000 Elsevier Sc
ience Ltd. All rights reserved.